Purchases and Sales Made in Q4 2023 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q4 2023. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
399KNew |
$683K - $1.27M
|
399K
$647K
|
|
|
Feb 14, 2024
Q4 2023
|
22 Nw, LP
Seattle, WA |
BUY
|
- |
300K+ 5.92% |
$513K - $951K
|
5.37M
$8.69M
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
131K+ 584.76% |
$223K - $414K
|
153K
$248K
|
|
|
Feb 05, 2024
Q4 2023
|
Landscape Capital Management, L.L.C.
|
BUY
|
- |
15KNew |
$25.7K - $47.6K
|
15K
$24.3K
|
|
|
Feb 14, 2024
Q4 2023
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
1.22KNew |
$2.08K - $3.86K
|
1.22K
$1.97K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
23+ 47.92% |
$39.3 - $72.9
|
71
$115
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
4New |
$6.84 - $12.7
|
4
$6.48
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 5.17% |
$5.13 - $9.51
|
61
$98.8
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-48- 1.14% |
$82.1 - $152
|
4.15K
$6.71K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-11.7K- 56.35% |
$20.1K - $37.2K
|
9.1K
$14.7K
|
|
|
Jan 12, 2024
Q4 2023
|
Lvw Advisors, LLC
|
SELL
|
- |
-29.3K- 4.36% |
$50.1K - $92.9K
|
643K
$1.04M
|